UTHR
United Therapeutics Corporation
541.70$
-5.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 350.0% | 83.2% | 54.7% | 18.1% | 12.7% | 11.2% | 10.6% | 10.7% | 10.6% | 10.7% | 12.3% | 12.2% | 12.0% | 13.0% | 11.7% | 9.8% | 4.7% | 4.5% | 6.1% | 12.2% | 8.1% | 7.3% | 7.3% | 7.6% | 11.1% | 10.8% | 12.1% | |
| 100.0% | -250.0% | 16.8% | 45.3% | 81.9% | 87.3% | 88.8% | 89.4% | 89.3% | 89.4% | 89.3% | 87.7% | 87.8% | 88.0% | 87.0% | 88.3% | 90.2% | 95.3% | 95.5% | 93.9% | 87.8% | 91.9% | 92.7% | 92.7% | 92.4% | 88.9% | 89.2% | 87.9% | |
| 11,000.0% | 7,675.0% | 3,425.0% | 568.6% | 88.9% | 66.4% | 41.6% | 31.1% | 36.1% | 39.5% | 85.0% | 33.0% | 27.6% | 24.2% | 18.9% | 26.8% | 18.8% | 16.7% | 9.2% | 15.3% | 22.0% | 81.6% | 24.1% | 32.0% | 16.7% | 17.5% | 16.7% | 17.3% | |
| – | 1,250.0% | 572.7% | 295.6% | 38.0% | 42.5% | 29.3% | 21.3% | 33.8% | 46.9% | 33.5% | 47.7% | 33.1% | 21.1% | 22.0% | 35.3% | 23.2% | 24.4% | 14.5% | 15.4% | 12.7% | 19.0% | 24.9% | 23.9% | 21.5% | 17.0% | 18.8% | 19.2% | |
| 13,400.0% | 8,600.0% | 3,993.8% | 864.2% | 141.7% | 108.9% | 70.8% | 52.4% | 71.2% | 86.5% | 118.5% | 80.7% | 60.7% | 45.3% | 40.9% | 62.1% | 48.4% | 47.6% | 29.0% | 34.5% | 38.3% | 104.8% | 52.7% | 59.8% | 41.8% | 38.0% | 41.4% | 40.3% | |
| -13,300.0% | -8,850.0% | -3,977.1% | -818.9% | -59.8% | -21.6% | 17.9% | 37.0% | 18.2% | 3.0% | -29.1% | 7.0% | 27.2% | 42.8% | 46.0% | 26.2% | 41.8% | 47.7% | 66.4% | 47.2% | 49.5% | -12.9% | 40.0% | 33.0% | 50.6% | 50.9% | 47.9% | 47.7% | |
| – | 0.0% | 5.9% | 3.0% | 0.4% | 0.2% | 0.0% | 0.0% | 0.3% | 1.0% | 0.0% | 3.5% | 3.3% | 2.9% | 1.8% | 1.6% | 1.4% | 0.3% | 0.2% | 0.5% | 0.9% | 3.1% | 1.6% | 1.1% | 1.7% | 2.5% | 1.5% | 0.6% | |
| -12,800.0% | -8,825.0% | -4,205.5% | -650.6% | -78.5% | -18.7% | 21.0% | 41.0% | 25.0% | 7.9% | -25.7% | 5.1% | 24.5% | 40.2% | 48.1% | 25.0% | 40.8% | 71.3% | 66.3% | 44.6% | 46.6% | -11.4% | 43.1% | 35.2% | 49.1% | 54.7% | 53.5% | 53.9% | |
| – | -475.0% | -287.5% | -168.4% | -32.0% | -4.7% | -4.1% | -15.1% | -21.3% | -1.6% | -10.5% | -0.2% | 6.9% | 11.0% | 14.9% | 9.3% | 14.4% | 26.8% | 21.7% | 20.4% | 10.4% | -4.2% | 8.4% | 7.0% | 11.5% | 12.4% | 12.0% | 11.9% | |
| -12,800.0% | -8,375.0% | -3,689.6% | -650.6% | -78.5% | -18.7% | 21.0% | 56.1% | 46.3% | 9.4% | -15.2% | 5.3% | 17.5% | 29.3% | 33.2% | 15.6% | 26.4% | 44.5% | 44.6% | 24.2% | 36.2% | -7.2% | 34.7% | 28.2% | 37.6% | 42.3% | 41.5% | 41.9% | |
| -13,346.2% | -9,165.9% | -3,981.0% | -754.2% | -49.4% | -17.2% | 24.2% | 43.2% | 18.2% | 10.5% | -24.1% | 11.6% | 30.7% | 45.9% | 52.9% | 29.0% | 44.6% | 73.8% | 68.2% | 61.1% | 51.5% | -5.2% | 43.6% | 43.7% | 53.7% | 59.6% | 57.5% | 57.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.